DDR2 kinase inhibition in squamous cell lung carcinomas

$236,209P01FY2013CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Matthew L Meyersoncontact

Linked publications & trials

Paper 39471218 Paper 38523074 Paper 38164587 Paper 38113333 Paper 37516774 Paper 36525973 Paper 35892819 Paper 35534503 Paper 35422503 Paper 35404393 Paper 35395071 Paper 35378251 Paper 34470822 Paper 33753926 Paper 32646968 Paper 32510788 Paper 32415712 Paper 32209571 Paper 31935369 Paper 31883968 Paper 31581174 Paper 31273063 Paper 31092401 Paper 30988284 Paper 30595531 Paper 30575730 Paper 30455465 Paper 30297358 Paper 30205046 Paper 30087114 Paper 29945997 Paper 29298799 Paper 29259014 Paper 29101163 Paper 29101114 Paper 29083409 Paper 29054992 Paper 28408401 Paper 28270508 Paper 28178529 Paper 28145866 Paper 28038940 Paper 28011204 Paper 27626175 Paper 27312177 Paper 27260156 Paper 27251290 Paper 27147599 Paper 27068336 Paper 26582713 Paper 26390252 Paper 26375053 Paper 26282169 Paper 26280531 Paper 26206333 Paper 26094118 Paper 26069186 Paper 26036643 Paper 26014096 Paper 25948633 Paper 25939061 Paper 25833960 Paper 25759024 Paper 25629630 Paper 25519892 Paper 25490451 Paper 25365225 Paper 25326665 Paper 25173427 Paper 25164010 Paper 25056707 Paper 25035393 Paper 24954536 Paper 24931608 Paper 24909170 Paper 24794706 Paper 24768818 Paper 24722148 Paper 24590290 Paper 24589777 Paper 24469055 Paper 24444711 Paper 24362534 Paper 24353160 Paper 24327273 Paper 24296828 Paper 24260500 Paper 24202392 Paper 24086281 Paper 24078774 Paper 24063894 Paper 24045185 Paper 24019492 Paper 23999436 Paper 23980093 Paper 23921124 Paper 23899692 Paper 23786770 Paper 23715154 Paper 23680150

View original record on NIH RePORTER →